AAAAAA
Results:
1-7
|
Results: 7
Authors:
Hassin-Baer, S
Sirota, P
Korczyn, AD
Treves, TA
Epstein, B
Shabtai, H
Martin, T
Litvinjuk, Y
Giladi, N
Citation: S. Hassin-baer et al., Clinical characteristics of neuroleptic-induced parkinsonism, J NEURAL TR, 108(11), 2001, pp. 1299-1308
Authors:
Portman, AT
Giladi, N
Leenders, KL
Maguire, P
Veenma-van der Duin, L
Swart, J
Pruim, J
Simon, ES
Hassin-Baer, S
Korczyn, AD
Citation: At. Portman et al., The nigrostriatal dopaminergic system in familial early onset parkinsonismwith parkin mutations, NEUROLOGY, 56(12), 2001, pp. 1759-1762
Authors:
Cohen, YC
Hassin-Baer, S
Olmer, L
Barishev, R
Goldhammer, Y
Freedman, L
Mozes, B
Citation: Yc. Cohen et al., MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment, MULT SCLER, 6(5), 2000, pp. 355-361
Authors:
Hassin-Baer, S
Korczyn, AD
Giladi, N
Citation: S. Hassin-baer et al., An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment, J NEURAL TR, 107(10), 2000, pp. 1187-1189
Authors:
Hassin-Baer, S
Bar-Shira, A
Gilad, S
Galanty, Y
Khosravi, R
Lossos, A
Giladi, N
Weitz, R
Ben-Zeev, B
Goldhammer, Y
Shiloh, Y
Citation: S. Hassin-baer et al., Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia, J NEUROL, 246(8), 1999, pp. 716-719
Authors:
Achiron, A
Gabbay, U
Gilad, R
Hassin-Baer, S
Barak, Y
Gornish, M
Elizur, A
Goldhammer, Y
Sarova-Pinhas, I
Citation: A. Achiron et al., Intravenous immunoglobulin treatment in multiple sclerosis - Reply, NEUROLOGY, 52(1), 1999, pp. 215-215
Authors:
Steiner, I
Cohen, O
Leker, RR
Rubinovitch, B
Handsher, R
Hassin-Baer, S
Gilden, DH
Sadeh, M
Citation: I. Steiner et al., Subacute painful lumbosacral polyradiculoneuropathy in immunocompromised patients, J NEUR SCI, 162(1), 1999, pp. 91-93
Risultati:
1-7
|